What Your Doctor May Not Tell You About Autoimmune Disorders: The Revolutionary, Drug-Free Treatments for Thyroid Disease, Lupus, MS, IBD, Chronic Fatigue; Rheumatoid Arthritis, and Other Diseases
The Street (Free subscription) | 8 hours ago
PRINCETON, N.J. (Bristol-Myers Squibb acquired worldwide rights to an experimental rheumatoid arthritis drug from privately held Alder Pharmaceuticals, the companies announced Tuesday. More from Adam Feuerstein The drug, ALD518, is an injectable monoclonal antibody that targets and blocks the production of IL-6, a molecule that plays role in the inflammation, swelling, pain...
Indy Star (Free subscription) | 11/04/2009
WASHINGTON -- A fast-growing category of prescription drugs that are among the most expensive on the market could, for the first time, face competition from generic competitors under the health-care bills moving through Congress.
The Puget Sound Business Journal (Free subscription) | 7 hours ago
Alder Biopharmaceuticals Inc. said it’s signed a deal with Bristol-Myers Squibb Co. to commercialize the Bothell biotech’s rheumatoid arthritis drug. (BMY)
The Street (Free subscription) | 6 hours ago
... is being called "exceptional" by the analysts at Cowen. More updates to come... Bristol Licenses Arthritis Drug(At 9:20 AM ET) Bristol-Myers Squibb() acquired worldwide rights to an experimental rheumatoid arthritis drug from privately held Alder Pharmaceuticals, the companies announced Tuesday. The drug, ALD518, is an injectable monoclonal antibody that...
